Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal Cancer

We analyzed the results of previously treated patients with metastatic colorectal cancer (mCRC) who received regorafenib plus FOLFIRI with the irinotecan dose escalation on the basis of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping. Thirteen patients with previously treated mCR...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Res
Main Authors: Ma, Cheng-Jen, Huang, Ching-Wen, Yeh, Yung-Sung, Tsai, Hsiang-Lin, Hu, Huang-Ming, Wu, I-Chen, Cheng, Tian-Lu, Wang, Jaw-Yuan
Formato: Artigo
Idioma:Inglês
Publicado: Cognizant Communication Corporation 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840952/
https://ncbi.nlm.nih.gov/pubmed/27938508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/97818823455816X14786040691928
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares